Live from the NIH registry
Studies recruiting near Nashua right now
Top 25 of 265 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Dartmouth Cancer Center - Nashua — Nashua, New Hampshire (1.6 mi)
· Sponsor: SWOG Cancer Research Network
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
Diabetes Mellitus, Hypertension
N/A
Interventional 1,022 participants sought
Dartmouth Hitchcock Clinics Manchester — Manchester, New Hampshire (17.1 mi)
· Sponsor: Dartmouth-Hitchcock Medical Center
Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer (NMIBC)
N/A
Interventional 56 participants sought
Lahey Hospital and Medical Center — Burlington, Massachusetts (22.6 mi)
· Sponsor: Lahey Clinic
Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet
Cystic Fibrosis (CF), Cystic Fibrosis Gastrointestinal Disease
N/A
Interventional 20 participants sought
Dartmouth Health Children's — Manchester, New Hampshire (17.1 mi)
· Sponsor: Dartmouth-Hitchcock Medical Center
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Elliot Hospital — Manchester, New Hampshire (17.1 mi)
· Sponsor: SWOG Cancer Research Network
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Burlington, Massachusetts (22.6 mi)
· Sponsor: TG Therapeutics, Inc.
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Non-obstructive Hypertrophic Cardiomyopathy
Phase 2
Interventional 165 participants sought
Imbria Investigational Site — Burlington, Massachusetts (22.6 mi)
· Sponsor: Imbria Pharmaceuticals, Inc.
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Schizophrenia
N/A
Observational 300 participants sought
Local Institution - 0008 — Belmont, Massachusetts (29.1 mi)
· Sponsor: Bristol-Myers Squibb
A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
Phelan-McDermid Syndrome
Phase 3
Interventional 160 participants sought
Neuren PMS-301 Site#104 — Lexington, Massachusetts (24.9 mi)
· Sponsor: Neuren Pharmaceuticals Limited
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Acute Respiratory Distress Syndrome, ARDS
Phase 3
Interventional 970 participants sought
Direct Biologics Investigational Site — Burlington, Massachusetts (22.6 mi)
· Sponsor: Direct Biologics, LLC
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Overweight, Obesity
Phase 3
Interventional 900 participants sought
MedVadis Research Corporation — Waltham, Massachusetts (28.8 mi)
· Sponsor: Eli Lilly and Company
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
Rumination
N/A
Interventional 158 participants sought
McLean Hospital — Belmont, Massachusetts (29.1 mi)
· Sponsor: Mclean Hospital
Individually Targeted Neuromodulation for Contamination-based OCD
Obsessive-Compulsive Disorder
N/A
Interventional 50 participants sought
McLean Hospital — Belmont, Massachusetts (29.1 mi)
· Sponsor: Mclean Hospital
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Burlington, Massachusetts (22.6 mi)
· Sponsor: 89bio, Inc.
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Southern New Hampshire Diabetes and Endocrinology /ID# 257841 — Nashua, New Hampshire (1.6 mi)
· Sponsor: AbbVie
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
Dana Farber-Merrimack Valley — Methuen, Massachusetts (15.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Pharmacologic Augmentation of TMS for Depression With D-serine
Depression
Phase 1
Interventional 60 participants sought
McLean Hospital — Belmont, Massachusetts (29.1 mi)
· Sponsor: Mclean Hospital
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Healthy Adult Participants
N/A
Observational 15 participants sought
Decentralized / At-Home Participation (U.S.) — Manchester, New Hampshire (17.1 mi)
· Sponsor: Ecotera Health LLC
Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia
Schizophrenia, Schizo Affective Disorder
N/A
Interventional 68 participants sought
McLean Hospital — Belmont, Massachusetts (29.1 mi)
· Sponsor: Mclean Hospital
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Lowell General Hospital — Lowell, Massachusetts (11.9 mi)
· Sponsor: NRG Oncology
Utilizing Battlefield Acupuncture to Treat Chronic Pain
Chronic Pain, Substance Use Disorders
N/A
Interventional 125 participants sought
Bedford VA Healthcare System — Bedford, Massachusetts (20.9 mi)
· Sponsor: Edith Nourse Rogers Memorial Veterans Hospital
Stress Dynamics and Familial Risk for Depression in Female Adolescents
Major Depressive Disorder
N/A
Interventional 148 participants sought
McLean Hospital — Belmont, Massachusetts (29.1 mi)
· Sponsor: Mclean Hospital
Buspirone for Anxiety in Autistic Youth
Anxiety, Autism Spectrum Disorder
Phase 4
Interventional 20 participants sought
Lurie Center — Lexington, Massachusetts (24.9 mi)
· Sponsor: Massachusetts General Hospital
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (17.1 mi)
· Sponsor: American Society of Clinical Oncology
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Tufts Medical Center Cancer Center Stoneham — Stoneham, Massachusetts (27.2 mi)
· Sponsor: National Cancer Institute (NCI)